← Back to contracts

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

US · MD National Institutes of Health (NIH) / National Institute of Neurological Disorders and Stroke (NINDS) grant open #PAR-25-215
Response due Nov 12, 2027 · 00:00 UTC

Summary

The National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS), is offering a K22 Career Transition Award targeted at intramural clinician-scientists seeking to transition to extramural research positions. The award supports early-career researchers in the neurological disorders and stroke domain. Clinical trials are explicitly excluded from this funding opportunity. The opportunity opened in December 2024 and remains open through November 2027.

What they want

Technical requirements
  • Clinical trials are not allowed under this funding opportunity (PAR-25-215)
  • Applicants must be NINDS intramural clinician-scientists transitioning to extramural positions

How they evaluate

Submission: Grants.gov federal grants portal (electronic submission)

Risks & flags

  • Eligibility is explicitly restricted to NINDS intramural clinician-scientists, effectively limiting competition to a very narrow, pre-identified pool of candidates
  • Long open window (2024–2027) with rolling submissions may favor incumbents with advance knowledge of internal review timelines

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541714
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Career Transition Award for NINDS Intramur…
Due Nov 12
Onboard ↗